In addition to LAG3, two other important checkpoint molecules expressed by tumor cells, namely, the PD-L1 ligand (CD274) and its paralog PDCD1LG2, were significantly decreased in the high-risk groups. This evidence concerns the gene PDCD1LG2 and neoplasm.